for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Novartis aims to bottle more than 50 mln doses of BioNTech COVID-19 vaccine in 2021

ZURICH, June 22 (Reuters) - Novartis aims to help manufacture more than 50 million doses of BioNTech’s COVID-19 vaccine in 2021 at its Stein, Switzerland fill-and-finish facility, the Swiss drugmaker said, after the European Union’s drug regulator approved the bottling plant. (Reporting by John Miller Editing by Chris Reese)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up